The novel coronavirus disease 2019 (COVID‐19) is the cause of an acute respiratory illness
which has spread around the world. The virus infects the host by binding to the angiotensin …

It is considered that COVID‐19's pandemic expansion is responsible for the particular
increase in deaths, especially among the population with comorbidities. The health system …

The gut is a well-established route of infection and target for viral damage by SARS-CoV-2.
This is supported by the clinical observation that about half of COVID-19 patients exhibit …

The diagnosis and treatment of manifestations of COVID-19 have evolved significantly since
the onset of the pandemic. With an expanding understanding of the virus and its impact on …

Abstract Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the world,
causing a pandemic that has resulted in more than 5 million deaths globally. The …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may lead to
coronavirus disease 2019 (COVID-19) which, in turn, may be associated with multiple organ …

The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) responsible
for the coronavirus disease outbreak initiated in 2019 (COVID-19) has been shown to affect …

SARS-CoV-2 is the viral agent of COVID-19, a pandemic that surfaced in 2019. Although
predominantly a respiratory ailment, patients with COVID-19 can have gastrointestinal (GI) …

Inflammatory bowel disease (IBD) is a chronic recurrent inflammation of the gastrointestinal
tract (GIT). IBD patients are susceptible to various infections such as viral infections due to …

BACKGROUND It is common for severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection to occur in the gastrointestinal tract, which can present itself as an initial …